Author： Zhu Y-P.
Publisher： Adis International
ISSN： 1176-2551
Source： Adverse Drug Reactions & Toxicological Reviews (now known as Toxicological Reviews), Vol.21, Iss.4, 2002-01, pp. : 171-177
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Aprotinin and renal dysfunction: what does history teach us?
Expert Opinion on Drug Safety, Vol. 8, Iss. 1, 2009-01 ,pp. :
Chinese herb nephropathy seen in 12 more patients
Inpharma, Vol. 1, Iss. 1228, 2000-01 ,pp. :
Drug-Herb Interactions: Eliminating Toxicity with Hard Drug Design
Current Pharmaceutical Design, Vol. 12, Iss. 35, 2006-12 ,pp. :
Advantages of Nanotechnology- Based Chinese Herb Drugs on Biological Activities
Current Drug Metabolism, Vol. 10, Iss. 8, 2009-01 ,pp. :